Logo image of SPNT

SIRIUSPOINT LTD (SPNT) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:SPNT - BMG8192H1060 - Common Stock

20.44 USD
+0.33 (+1.64%)
Last: 1/12/2026, 4:15:00 PM
20.44 USD
0 (0%)
After Hours: 1/12/2026, 4:15:00 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to SPNT. SPNT was compared to 146 industry peers in the Insurance industry. SPNT may be in some trouble as it scores bad on both profitability and health. SPNT has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year SPNT was profitable.
SPNT had a positive operating cash flow in the past year.
SPNT had positive earnings in 4 of the past 5 years.
Each year in the past 5 years SPNT had a positive operating cash flow.
SPNT Yearly Net Income VS EBIT VS OCF VS FCFSPNT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M

1.2 Ratios

SPNT's Return On Assets of 1.49% is in line compared to the rest of the industry. SPNT outperforms 43.84% of its industry peers.
Looking at the Return On Equity, with a value of 8.39%, SPNT is in line with its industry, outperforming 40.41% of the companies in the same industry.
SPNT has a Return On Invested Capital of 2.65%. This is comparable to the rest of the industry: SPNT outperforms 56.16% of its industry peers.
Industry RankSector Rank
ROA 1.49%
ROE 8.39%
ROIC 2.65%
ROA(3y)0.13%
ROA(5y)0.97%
ROE(3y)1.05%
ROE(5y)2.81%
ROIC(3y)N/A
ROIC(5y)N/A
SPNT Yearly ROA, ROE, ROICSPNT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

With a Profit Margin value of 6.49%, SPNT is not doing good in the industry: 60.96% of the companies in the same industry are doing better.
In the last couple of years the Profit Margin of SPNT has declined.
The Operating Margin of SPNT (13.29%) is comparable to the rest of the industry.
In the last couple of years the Operating Margin of SPNT has declined.
Industry RankSector Rank
OM 13.29%
PM (TTM) 6.49%
GM N/A
OM growth 3YN/A
OM growth 5Y-4.18%
PM growth 3Y45.15%
PM growth 5Y-20.65%
GM growth 3YN/A
GM growth 5YN/A
SPNT Yearly Profit, Operating, Gross MarginsSPNT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60 -80

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), SPNT is destroying value.
SPNT has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, SPNT has more shares outstanding
The debt/assets ratio for SPNT has been reduced compared to a year ago.
SPNT Yearly Shares OutstandingSPNT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
SPNT Yearly Total Debt VS Total AssetsSPNT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

SPNT has a debt to FCF ratio of 3.21. This is a good value and a sign of high solvency as SPNT would need 3.21 years to pay back of all of its debts.
The Debt to FCF ratio of SPNT (3.21) is comparable to the rest of the industry.
SPNT has a Debt/Equity ratio of 0.31. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of SPNT (0.31) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 3.21
Altman-Z N/A
ROIC/WACC0.31
WACC8.65%
SPNT Yearly LT Debt VS Equity VS FCFSPNT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
SPNT Yearly Current Assets VS Current LiabilitesSPNT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

5

3. Growth

3.1 Past

SPNT shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by 0.00%.
The earnings per share for SPNT have been decreasing by -14.97% on average. This is quite bad
SPNT shows a small growth in Revenue. In the last year, the Revenue has grown by 2.43%.
SPNT shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 22.87% yearly.
EPS 1Y (TTM)0%
EPS 3Y-21.17%
EPS 5Y-14.97%
EPS Q2Q%2333.33%
Revenue 1Y (TTM)2.43%
Revenue growth 3Y8.91%
Revenue growth 5Y22.87%
Sales Q2Q%15.21%

3.2 Future

The Earnings Per Share is expected to grow by 43.31% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 3.39% on average over the next years.
EPS Next Y155%
EPS Next 2Y61.01%
EPS Next 3Y43.31%
EPS Next 5YN/A
Revenue Next Year-2.63%
Revenue Next 2Y2.01%
Revenue Next 3Y3.39%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
SPNT Yearly Revenue VS EstimatesSPNT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
SPNT Yearly EPS VS EstimatesSPNT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 12.86, the valuation of SPNT can be described as correct.
The rest of the industry has a similar Price/Earnings ratio as SPNT.
The average S&P500 Price/Earnings ratio is at 27.25. SPNT is valued rather cheaply when compared to this.
The Price/Forward Earnings ratio is 8.21, which indicates a very decent valuation of SPNT.
Based on the Price/Forward Earnings ratio, SPNT is valued a bit cheaper than the industry average as 70.55% of the companies are valued more expensively.
SPNT's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 23.98.
Industry RankSector Rank
PE 12.86
Fwd PE 8.21
SPNT Price Earnings VS Forward Price EarningsSPNT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, SPNT is valued a bit cheaper than 71.23% of the companies in the same industry.
SPNT's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 11.21
EV/EBITDA 6.26
SPNT Per share dataSPNT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

SPNT's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
SPNT's earnings are expected to grow with 43.31% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.08
PEG (5Y)N/A
EPS Next 2Y61.01%
EPS Next 3Y43.31%

0

5. Dividend

5.1 Amount

SPNT does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

SIRIUSPOINT LTD

NYSE:SPNT (1/12/2026, 4:15:00 PM)

After market: 20.44 0 (0%)

20.44

+0.33 (+1.64%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)10-30 2025-10-30/amc
Earnings (Next)02-16 2026-02-16/amc
Inst Owners87.28%
Inst Owner Change-0.12%
Ins Owners1.59%
Ins Owner Change-6.84%
Market Cap2.39B
Revenue(TTM)2.86B
Net Income(TTM)185.50M
Analysts82.5
Price Target22.95 (12.28%)
Short Float %1.85%
Short Ratio2.98
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0.11
Dividend Growth(5Y)N/A
DP8.63%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)13.28%
Min EPS beat(2)-13.77%
Max EPS beat(2)40.33%
EPS beat(4)2
Avg EPS beat(4)0.89%
Min EPS beat(4)-131.86%
Max EPS beat(4)108.87%
EPS beat(8)5
Avg EPS beat(8)14.3%
EPS beat(12)8
Avg EPS beat(12)37.79%
EPS beat(16)9
Avg EPS beat(16)12%
Revenue beat(2)1
Avg Revenue beat(2)1.95%
Min Revenue beat(2)-9.34%
Max Revenue beat(2)13.24%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-10%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-6.59%
EPS NY rev (1m)0%
EPS NY rev (3m)11.49%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.98%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.09%
Valuation
Industry RankSector Rank
PE 12.86
Fwd PE 8.21
P/S 0.84
P/FCF 11.21
P/OCF 11.21
P/B 1.08
P/tB 1.14
EV/EBITDA 6.26
EPS(TTM)1.59
EY7.78%
EPS(NY)2.49
Fwd EY12.18%
FCF(TTM)1.82
FCFY8.92%
OCF(TTM)1.82
OCFY8.92%
SpS24.47
BVpS18.92
TBVpS17.86
PEG (NY)0.08
PEG (5Y)N/A
Graham Number26.02
Profitability
Industry RankSector Rank
ROA 1.49%
ROE 8.39%
ROCE 3.06%
ROIC 2.65%
ROICexc 2.78%
ROICexgc 3.78%
OM 13.29%
PM (TTM) 6.49%
GM N/A
FCFM 7.45%
ROA(3y)0.13%
ROA(5y)0.97%
ROE(3y)1.05%
ROE(5y)2.81%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-10.36%
ROICexc growth 3YN/A
ROICexc growth 5Y-11.48%
OM growth 3YN/A
OM growth 5Y-4.18%
PM growth 3Y45.15%
PM growth 5Y-20.65%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.23
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 3.21
Debt/EBITDA 1.74
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion 54.38%
Profit Quality 114.77%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score5
WACC8.65%
ROIC/WACC0.31
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3Y-21.17%
EPS 5Y-14.97%
EPS Q2Q%2333.33%
EPS Next Y155%
EPS Next 2Y61.01%
EPS Next 3Y43.31%
EPS Next 5YN/A
Revenue 1Y (TTM)2.43%
Revenue growth 3Y8.91%
Revenue growth 5Y22.87%
Sales Q2Q%15.21%
Revenue Next Year-2.63%
Revenue Next 2Y2.01%
Revenue Next 3Y3.39%
Revenue Next 5YN/A
EBIT growth 1Y-22.34%
EBIT growth 3YN/A
EBIT growth 5Y17.74%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-51.16%
FCF growth 3Y260.08%
FCF growth 5Y-11.94%
OCF growth 1Y-51.16%
OCF growth 3Y260.08%
OCF growth 5Y-11.94%

SIRIUSPOINT LTD / SPNT FAQ

What is the fundamental rating for SPNT stock?

ChartMill assigns a fundamental rating of 4 / 10 to SPNT.


What is the valuation status for SPNT stock?

ChartMill assigns a valuation rating of 6 / 10 to SIRIUSPOINT LTD (SPNT). This can be considered as Fairly Valued.


Can you provide the profitability details for SIRIUSPOINT LTD?

SIRIUSPOINT LTD (SPNT) has a profitability rating of 3 / 10.


How financially healthy is SIRIUSPOINT LTD?

The financial health rating of SIRIUSPOINT LTD (SPNT) is 3 / 10.


What is the earnings growth outlook for SIRIUSPOINT LTD?

The Earnings per Share (EPS) of SIRIUSPOINT LTD (SPNT) is expected to grow by 155% in the next year.